ARTICLE | Clinical News
Enbrel regulatory update
November 9, 2016 10:01 PM UTC
FDA approved an sBLA for Enbrel etanercept from Amgen to treat chronic moderate to severe plaque psoriasis in patients ages 4-17 who are candidates for systemic therapy or phototherapy. Enbrel is appr...
BCIQ Company Profiles